Atlas Trials

Pharmacokinetic Study of Oral ALXN1840 in Japanese and Non-Japanese Adult Healthy Participants

Clinical trial NCT05641311 · COMPLETED

Trial details

NCT number
NCT05641311
Sponsor
Alexion Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Wilson Disease
Start date
2019-02-20
Primary completion
2019-05-02
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.